Published July 25, 1989 | Version v1
Patent

Diagnostic procedures using radio labeled sucralfate and derivatives or precursors thereof

Description

This patent describes a method of clinical evaluation of conditions associated with loss of mucosal integrity in humans. It comprises: administering orally to a subject in need of such evaluation an effective amount of a polysulfated disaccharide salt labeled by association with a carrier containing a radioisotope detectable by scintigraphic imaging, followed by scintigraphic imaging of the gastrointestinal area. This paper describes a composition useful for evaluation by radioimaging of conditions associated with loss of mucosal integrity. The composition comprises an effective amount of polysulfated disaccharide salt associated with a carrier containing a radioisotope detectable by scintigraphy

Availability note (English)

Patent and Trademark Office, Box 9, Washington, DC 20232.

Additional details

Publishing Information

Imprint Pagination
vp.
IPC:
Int. Cl. A61K 49/02; A61K 49/00.
IPC
Int. Cl. A61K 49/02; A61K 49/00.
Patent number
US patent document 4,851,209/A/

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
21028112
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
CHEMICAL COMPOSITION; GASTROINTESTINAL TRACT; IMAGES; LABELLED COMPOUNDS; MAN; MUCOUS MEMBRANES; ORAL ADMINISTRATION; SACCHARIDES; SALTS; SCINTISCANNING
Descriptors DEC
ANIMALS; CARBOHYDRATES; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; INTAKE; MAMMALS; ORGANIC COMPOUNDS; PRIMATES; RADIOISOTOPE SCANNING; VERTEBRATES